An overview of solutions to structure a traceable regulatory watch for digital medical devices: free official sources, QMS modules and specialised offerings.
Under the MDR (Regulation (EU) 2017/745, Medical Device Regulation), regulatory watch is not an optional good practice. It is part of the quality management system (QMS) requirements under the ISO 13485 standard, and Notified Bodies (NB) check it in audit just like risk management or document control. For a Digital Medical Device (SaMD) manufacturer, the choice of monitoring solution directly conditions the ability to anticipate a regulatory change rather than endure it.
Between the texts published on EUR-Lex, the guidances of the Medical Device Coordination Group (MDCG), the European Commission's decisions on EUDAMED and the national publications of the French National Agency for the Safety of Medicines and Health Products (ANSM), the volume of information to follow far exceeds what an occasional manual watch can absorb. Here is an overview of the available solutions, from the free baseline to specialised support offerings.
An untraceable watch is a potential non-conformity. NBs expect a documented process: defined frequency, identified sources, evidence of the review carried out. A lack of traceability can be raised in an internal audit as well as in a certification audit.
An unfiltered watch wastes a great deal of the regulatory teams' time. Regulatory watch absorbs considerable time: before they can even use a piece of information, teams have to sort what really concerns software medical devices and the standards that affect them from the stream of texts that do not apply to them.
Receiving an alert is not the same as measuring its impact. Identifying that a text has changed is a first step. Assessing what it concretely changes for the technical documentation or the QMS is another, often neglected for lack of time or in-house regulatory expertise.
1. The free official sources. EUR-Lex offers email notifications and RSS feeds on the MDR 2017/745 and IVDR 2017/746 texts. The European Commission's health site publishes the MDCG guidances, which clarify the interpretation of the regulation, for example on the qualification and classification of software. EUDAMED, whose first four modules (actor registration, UDI and devices, notified bodies and certificates, market surveillance) became mandatory on 28 May 2026 pursuant to implementing decision (EU) 2025/2371, is also a source to follow for its own registration deadlines. The ANSM and the HAS complete this baseline on the national side and on digital technologies and artificial intelligence in healthcare. This free base remains indispensable, but it requires knowing where to look and manually sorting what is relevant to your device.
2. Regulatory watch modules built into quality management (QMS) software. Some QMS software vendors for medical devices, focused on document control, CAPA (corrective and preventive actions) and risk management, offer a regulatory alert module as an add-on. The advantage is integration into a tool already used daily by quality teams. The limitation is that these modules often remain generalist and do not replace an expert impact analysis on a specific software device.
3. Specialised offerings from regulatory expertise firms. Several QARA (Quality and Regulatory Affairs) firms offer regulatory and standards watch as a service, with an optional impact analysis and action plan. Some combine artificial intelligence and human expertise to follow a large number of sources and produce a comparison of a text's changes from one version to the next. This is how we offer Synchro, a watch on SaMD that combines continuous AI monitoring and expert human selection, with three levels: a weekly generalist watch, a targeted watch according to activity and devices, and a strategic watch designed as a tool for anticipation and decision-making. This type of offering specifically meets the traceability need expected in audit, since each alert is documented and qualified.
4. The criteria for choosing.
How much bandwidth do your teams really have? An in-house watch means weekly hours of reading and documentation kept up without interruption, including during submission or audit periods. If no one has protected them in their schedule, the watch exists in the QMS but not in practice, and outsourcing becomes the only way to meet the requirement.
Is the watch software-specific? A generalist "medical devices" feed will flood you with texts on sterilisation or implants, and will let through changes to IEC 62304, the MDCG guides on software qualification and classification, or cybersecurity expectations.
Does the watch stop at the alert or go all the way to impact analysis? A raw alert remains an added cost as long as no one says whether your class is affected, which section of the technical documentation changes and which action to open, with a record usable in audit.
Synchro organises the regulatory watch of digital medical devices by filtering useful information with AI, with expert human selection as a second level. The scope is that of software: MDR 2017/745, IVDR 2017/746, ISO 13485, IEC 62304, CE marking requirements, notified bodies' positions. Each source is selected for its regulatory relevance, which removes the noise and unreliable content of open aggregators.
Two plans:
Essentiel is free: a weekly generalist but structured newsletter covering European regulatory news, the Commission's key decisions, MDR and IVDR developments and standards information.
Premium is built on a quote, around your activity: specialised sources adapted to your field, analysis of regulatory impacts on your products, contextualisation of risks and opportunities, prioritisation of critical alerts and regulatory competitive intelligence. It is the plan that meets the third criterion, that of the alert that goes all the way to impact.
.png)
